Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C29H38O4 |
| Molecular Weight | 450.6096 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(O)C(=O)C=C2C1=CC=C3[C@@]2(C)CC[C@@]4(C)[C@@H]5C[C@@](C)(CC[C@]5(C)CC[C@]34C)C(O)=O
InChI
InChIKey=KQJSQWZMSAGSHN-JJWQIEBTSA-N
InChI=1S/C29H38O4/c1-17-18-7-8-21-27(4,19(18)15-20(30)23(17)31)12-14-29(6)22-16-26(3,24(32)33)10-9-25(22,2)11-13-28(21,29)5/h7-8,15,22,31H,9-14,16H2,1-6H3,(H,32,33)/t22-,25-,26-,27+,28-,29+/m1/s1
| Molecular Formula | C29H38O4 |
| Molecular Weight | 450.6096 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11513350Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/10072949 | https://www.ncbi.nlm.nih.gov/pubmed/26000480
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11513350
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/10072949 | https://www.ncbi.nlm.nih.gov/pubmed/26000480
Celastrol is a pentacyclic triterpenoid isolated from the root extracts of Tripterygium wilfordii, a perrennial creeping plant indigenous to large area in Southern China. Celastrol possess antioxidant and anti-inflammatory and anticancer action. In the mouse model of rheumatoid arthritis it reduced inflammatory swelling, suppressed humoral and skin response and reduced pathological progression of joint. Celastrol demonstrated efficacy in transgenic mouse model of amyotrophic lateral sclerosis. Anticancer activity of celastrol was shown in xenograft models of prostate cancer. Celastrol suppresses food intake, blocks reduction of energy expenditure, and leads to up to 45% weight loss in hyperleptinemic diet-induced obese (DIO) mice by increasing leptin sensitivity. Celastrol acts by interfering with the activity of Hsp90, IKK-beta and proteasome S26 subunit.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2095165 Sources: https://www.ncbi.nlm.nih.gov/pubmed/19858214 |
|||
Target ID: O14920 Gene ID: 3551.0 Gene Symbol: IKBKB Target Organism: Homo sapiens (Human) |
|||
Target ID: CHEMBL2364701 Sources: https://www.ncbi.nlm.nih.gov/pubmed/16651429 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids. | 2015-10-20 |
|
| The quinone methide aurin is a heat shock response inducer that causes proteotoxic stress and Noxa-dependent apoptosis in malignant melanoma cells. | 2015-01-16 |
|
| Accumulation of heme oxygenase-1 (HSP32) in Xenopus laevis A6 kidney epithelial cells treated with sodium arsenite, cadmium chloride or proteasomal inhibitors. | 2014-11 |
|
| Celastrol ameliorates murine colitis via modulating oxidative stress, inflammatory cytokines and intestinal homeostasis. | 2014-03-05 |
|
| Celastrol prevents cadmium-induced neuronal cell death via targeting JNK and PTEN-Akt/mTOR network. | 2014-01 |
|
| Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells. | 2013-10 |
|
| A critical role for MAPK signalling pathways in the transcriptional regulation of toll like receptors. | 2013 |
|
| Celastrol induces apoptosis in non-small-cell lung cancer A549 cells through activation of mitochondria- and Fas/FasL-mediated pathways. | 2011-08 |
|
| Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication. | 2011-07-29 |
|
| Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L. | 2010-11-28 |
|
| Pharmacogenomic approach reveals a role for the x(c)- cystine/glutamate antiporter in growth and celastrol resistance of glioma cell lines. | 2010-03 |
|
| Calpain-mediated androgen receptor breakdown in apoptotic prostate cancer cells. | 2008-12 |
|
| Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. | 2006-10 |
|
| Tripterine inhibits the expression of adhesion molecules in activated endothelial cells. | 2006-08 |
Patents
Sample Use Guides
In collagen-induced arthritis study on mice, celastrol was administered orally at 15 and 30 mg/kg. In model of prostate cancer celastrol was administered at doses 1-3 mg/kg intraperitoneally.
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16984800
The ability of celastrol to inhibit NF-kB activation was studied in vitro in Jurkat cell line. Cells were preincubated with various concentrations of celastrol for 30 min prior to stimulation with TNF-alpha or PMA. After the stimulation, nuclear extracts were prepared and DNA-binding activity of NF-kB in the nuclear extracts was measured by electrophoretic mobility shift assays. Pretreatment of celastrol dose-dependently inhibited DNA-binding activity of NF-kB induced by TNF-a or PMA. The effect was apparent at concentrations of celastrol below 0.3 ug/ml.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:54:03 GMT 2025
by
admin
on
Mon Mar 31 22:54:03 GMT 2025
|
| Record UNII |
L8GG98663L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
70931
Created by
admin on Mon Mar 31 22:54:03 GMT 2025 , Edited by admin on Mon Mar 31 22:54:03 GMT 2025
|
PRIMARY | |||
|
DTXSID2040993
Created by
admin on Mon Mar 31 22:54:03 GMT 2025 , Edited by admin on Mon Mar 31 22:54:03 GMT 2025
|
PRIMARY | |||
|
34157-83-0
Created by
admin on Mon Mar 31 22:54:03 GMT 2025 , Edited by admin on Mon Mar 31 22:54:03 GMT 2025
|
PRIMARY | |||
|
L8GG98663L
Created by
admin on Mon Mar 31 22:54:03 GMT 2025 , Edited by admin on Mon Mar 31 22:54:03 GMT 2025
|
PRIMARY | |||
|
122724
Created by
admin on Mon Mar 31 22:54:03 GMT 2025 , Edited by admin on Mon Mar 31 22:54:03 GMT 2025
|
PRIMARY | |||
|
CELASTROL
Created by
admin on Mon Mar 31 22:54:03 GMT 2025 , Edited by admin on Mon Mar 31 22:54:03 GMT 2025
|
PRIMARY | |||
|
m3227
Created by
admin on Mon Mar 31 22:54:03 GMT 2025 , Edited by admin on Mon Mar 31 22:54:03 GMT 2025
|
PRIMARY | Merck Index |